Pacific Biosciences Of California | PACB - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Agilent USD 836M 9M 2026-06
Bruker USD 422.5M 21.1M 2026-06
Danaher USD 2.72B 63M 2026-09
General Electric Aerospace USD 9.33B 439M 2026-09
Illumina USD 389M 19M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Quidel USD 407M 486.5M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Standard Biotools USD 9.84M 2.58M 2026-03
Thermo Fisher Scientific USD 7.46B 72M 2026-09
Waters USD 1.16B 430M 2026-06